In this trial, dubbed the OCARINA II trial, Roche demonstrated that the SC Ocrevus dose was equivalent to the much longer IV dose; and that took away the one major edge Briumvi had - quicker and ...

Ocrevus comes as a liquid solution in single-dose vials. It’s given as an intravenous (IV) infusion (an injection into a vein given over time) by a healthcare professional. Ocrevus begins ...

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according to the company ...